BioCentury
ARTICLE | Company News

Draxis, Jubilant Organosys deal

April 14, 2008 7:00 AM UTC

Jubilant Organosys, an Indian CRO, will acquire radiopharmaceutical and manufacturing services company Draxis for US$6 per share, or about US$255 million in cash. Lazard Ltd. advised Jubilant Organosy...